Purchase Order 75N92019K00086

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostic products. The contract provides for the delivery of COAGUCHEK test strips and quality control products, which are used in conjunction with coagulation analyzers to monitor blood clotting factors. The contract has a ceiling value of $6,890.30 and a period of performance through November 30, 2022. This award is a...

This is a delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Werfen USA LLC, a for-profit limited liability company that manufactures in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care settings. The contract, valued at $111,604.51, is for the provision of a Benchtop Hemostasis System Coagulometer ACL TOP 550 CTS. The contract has a completion date of September 1, 2023 and was awarded on...

This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Diagnostica Stago Inc., a manufacturer of medical devices and consumables for coagulation testing. The contract, valued at $3,886.74, is to provide coagulation reagents and supplies such as prothrombin time, partial thromboplastin time, fibrinogen, and D-dimer testing capabilities to support clinical laboratory operations at VA and Department of Defense (DOD) medical facilities....

This is a firm fixed-price BPA call contract awarded by the Medical Command (MEDCOM) of the U.S. Department of the Army to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $243,121.91 award is for COBAS AMPLIPREP/COBAS TAQM, which provides chemistry and immunochemistry laboratory testing capabilities. The contract is not designated as a set-aside. Roche Diagnostics has previously received numerous prime...

This is a firm-fixed-price purchase order contract awarded by the Defense Health Agency to Sysmex America, Inc., a U.S. subsidiary of the Japanese company Sysmex Corporation. The contract is for the provision of a "Cost per Reportable Results Coagulation Analyzer" and has a ceiling value of $382,787.90. The contract has an ultimate completion date of September 30, 2029. The contract is not designated as a set-aside. Sysmex America, Inc. is the prime contractor, and no subcontractors...

This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services for use in clinical laboratories and point-of-care settings. The $435,102.83 firm fixed price contract is for coagulation CPRR (Coagulation Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen, and D-Dimer) testing. The contract is a Blanket Purchase Agreement (BPA) call under the Critical...

This is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs to Roche Diagnostics Corporation. The contract is for the provision of coagulation test strips, with a ceiling value of $1,485,782.71 and an ultimate completion date of December 30, 2020. The contract was awarded on December 31, 2015 and is not designated as a set-aside. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro...

This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Werfen USA LLC, a for-profit limited liability company based in Bedford, Massachusetts. The contract is for the provision of a COAGULATION INSTRUMENT - ACL TOP 350, with a ceiling value of $271,134.68 and a completion date of December 29, 2026. The contract was awarded on December 30, 2021 and does not have a small business set-aside designation. Werfen USA LLC is a manufacturer and supplier of in vitro...

<p>Roche Diagnostics Corporation has been awarded a firm fixed price blanket purchase agreement (BPA) call contract valued at $24,977 by the Defense Health Agency to provide COBAS assay tests. The contract has no set-aside designation and requires completion of the tests by September 30, 2022. As the sole awardee, Roche Diagnostics will deliver the requested clinical diagnostic assays from its location in Castleton, Indiana to support the Defense Health Agency's medical testing programs.</p>

<p>The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $540,000 firm fixed price blanket purchase agreement call contract to provide medical supplies and reagents such as COBAS OMNI processing plates, COBAS 6800/8800 SPEC diluent reagents, and COBAS PCR urine test kits. The place of performance will be Roche Diagnostics' facility located in Bethesda, Maryland. The period of performance is from February 23, 2022 through October 22, 2022.</p>